Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
100%
Diabetic Endothelial Dysfunction
100%
Diabetic
66%
Endothelial Cells
50%
In Vitro Model
50%
Genetic Factors
33%
Environmental Factors
33%
Diabetic Patients
33%
Metabolic Disorders
33%
Cell-based
16%
Diabetes
16%
Pathophysiology
16%
Risk Factors
16%
Cell-derived
16%
Induced Pluripotent Stem Cell Technology
16%
Personalized Medicine
16%
Drug Discovery
16%
Induced Pluripotent Stem Cell-derived Endothelial Cells
16%
Culture Conditions
16%
Endothelial Dysfunction
16%
Endothelial Function
16%
Diabetogenic
16%
RNA-seq Analysis
16%
Healthy Individuals
16%
Cardiovascular Complications
16%
High Prevalence
16%
Clinical Chemistry
16%
Screening Platform
16%
Angiotensin Receptor Blockers
16%
In Vitro Disease Models
16%
Transcriptome-wide
16%
Medicine and Dentistry
Induced Pluripotent Stem Cell
100%
Endothelial Dysfunction
100%
Diabetes Mellitus
85%
In Vitro
71%
Endothelial Cell
57%
Water-Electrolyte Imbalance
28%
Environmental Factor
28%
Prevalence
14%
Angiotensin Receptor Antagonist
14%
Cardiovascular Disease
14%
Pathophysiology
14%
Diabetes
14%
RNA Sequencing
14%
Personalized Medicine
14%
Endothelial Function
14%
Disease Model
14%
Transcriptome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Endothelial Dysfunction
100%
Metabolic Disorder
33%
Drug Discovery
16%
Prevalence
16%
Angiotensin Receptor Antagonist
16%
Pathophysiology
16%
Transcriptome
16%
Disease Model
16%
Cardiovascular Disease
16%
Neuroscience
Stem Cell
100%
Diabetes Mellitus
85%
In Vitro
71%
Metabolic Disorder
28%
Transcriptome
14%
Angiotensin Receptor
14%
RNA-Seq
14%
Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
100%
Metabolic Disorder
33%
Genetics
33%
RNA Sequencing
16%
Clinical Biochemistry
16%
Prevalence
16%
Angiotensin Receptor
16%
Transcriptome
16%
Human Induced Pluripotent Stem Cell
16%